BARK Faces Urgent Call for Strategic Action Amid Market Challenges

Eric Ebert of Shay Capital has urged BARK's board of directors to take immediate action to enhance shareholder value. The company has $85 million in cash and $98 million in inventory, and Ebert recommends a $25 million share buyback, leveraging inventory for financing, and expanding into new product categories such as vitamins and DNA testing kits. He emphasizes the importance of swift action to optimize BARK's financial resources and position the company as a leader in the pet health ecosystem.